{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:09:13Z","timestamp":1791889753538,"version":"4.3.4"},"reference-count":97,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.4158\/ep161721.ra","type":"journal-article","created":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T15:53:45Z","timestamp":1497455625000},"page":"726-737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["An Individualized Approach to the Evaluation of Cushing Syndrome"],"prefix":"10.1016","volume":"23","author":[{"given":"Susmeeta T.","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"on behalf of the AACE Adrenal Scientific Committee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP161721.RA_bb0010","first-page":"117","article-title":"Incidence and late prognosis of Cushing's syndrome: a population based study","volume":"86","author":"Lindholm","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0015","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","article-title":"Morbidity and mortality in Cushing's disease: an epidemiological approach","volume":"40","author":"Etxabe","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161721.RA_bb0020","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/EJE-11-0272","article-title":"The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics","volume":"165","author":"Valassi","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP161721.RA_bb0025","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing's syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"key":"10.4158\/EP161721.RA_bb0030","first-page":"281","article-title":"Cushing's syndrome: epidemiology and developments in disease management","volume":"7","author":"Sharma","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.4158\/EP161721.RA_bb0035","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1210\/jc.2003-030254","article-title":"Occult Cushing's syndrome in type-2 diabetes","volume":"88","author":"Catargi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0040","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1210\/jc.2012-1323","article-title":"Screening of Cushing's syndrome in outpatients with type 2 diabetes: results of a prospective multicentric study in Italy","volume":"97","author":"Terzolo","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0045","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1210\/jc.2009-2453","article-title":"Is there value in routine screening for Cushing's syndrome in patients with diabetes?","volume":"95","author":"Mullan","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0050","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2265.2007.02865.x","article-title":"Screening of Cushing's syndrome in adult patients with newly diagnosed diabetes mellitus","volume":"67","author":"Reimondo","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161721.RA_bb0055","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1210\/jc.2004-2527","article-title":"Cushing's syndrome due to ectopic corticotrophin secretion: twenty years experience at National Institutes of Health","volume":"90","author":"Ilias","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0060","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1210\/jc.2005-1542","article-title":"The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up","volume":"91","author":"Isidori","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0065","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1056\/NEJMoa1215245","article-title":"Intraadrenal corticotrophin in bilateral macronodular adrenal hyperplasia","volume":"369","author":"Louiset","year":"2013","journal-title":"N Eng J Med"},{"key":"10.4158\/EP161721.RA_bb0070","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1056\/NEJMe1312792","article-title":"Heredity and cortisol regulation in bilateral macronodular adrenal hyperplasia","volume":"369","author":"Lacroix","year":"2013","journal-title":"N Eng J Med"},{"key":"10.4158\/EP161721.RA_bb0075","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0080","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1210\/jc.2008-2766","article-title":"Specificity of screening tests for Cushing's syndrome in an overweight and obese population","volume":"94","author":"Baid","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0085","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJM199409083311002","article-title":"Cushing's syndrome in children and adoloscents: Presentation, diagnosis, and therapy","volume":"331","author":"Magiakou","year":"1994","journal-title":"N Eng J Med"},{"key":"10.4158\/EP161721.RA_bb0090","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1749-6632.2002.tb04419.x","article-title":"Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases","volume":"970","author":"Torpy","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 1","key":"10.4158\/EP161721.RA_bb0095","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000314319","article-title":"Pathophysiology of diabetes mellitus in Cushing's syndrome","volume":"92","author":"Pivonello","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"Suppl 1","key":"10.4158\/EP161721.RA_bb0100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000314213","article-title":"Pathophysiology of dyslipidemia in Cushing's syndrome","volume":"92","author":"Arnaldi","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.4158\/EP161721.RA_bb0105","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1530\/eje.0.1490543","article-title":"Hepatic steatosis in Cushing's syndrome: a radiological assessment using computerized tomography","volume":"149","author":"Rockall","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP161721.RA_bb0110","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1530\/eje.0.1490561","article-title":"Computed tomography assessment of fat distribution in male and female patients with Cushing's syndrome","volume":"149","author":"Rockall","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP161721.RA_bb0115","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/cen.12094","article-title":"Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment","volume":"78","author":"van der Pas","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161721.RA_bb0120","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2265.2011.04055.x","article-title":"Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission","volume":"75","author":"Giordano","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161721.RA_bb0125","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1210\/jc.2012-3547","article-title":"Coronary artery disease detected by multislice computed tomography in patients after long-term cure of Cushing's syndrome","volume":"98","author":"Barahona","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0130","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2265.1995.tb02614.x","article-title":"Psychopathology in patients with endogenous Cushing's syndrome: \u2018atypical\u2019 or melancholic features","volume":"43","author":"Dorn","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"Suppl 1","key":"10.4158\/EP161721.RA_bb0135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000314317","article-title":"Neuropsychiatric disorders in Cushing's syndrome","volume":"92","author":"Pereira","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.4158\/EP161721.RA_bb0140","first-page":"1949","article-title":"Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism","volume":"87","author":"Bourdeau","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0145","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/0006-3223(92)90079-F","article-title":"Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome","volume":"32","author":"Starkman","year":"1992","journal-title":"Biol Psychiatry"},{"key":"10.4158\/EP161721.RA_bb0150","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4158\/EP12247.OR","article-title":"Persistence of Cushing's disease symptoms and comorbidities after surgical cure: a long-term, integral evaluation","volume":"19","author":"Espinosa-de-Los-Monteros","year":"2013","journal-title":"Endocr Pract"},{"key":"10.4158\/EP161721.RA_bb0155","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/EJE-12-0308","article-title":"Impaired quality of life in patients in long-term remission of Cushing's syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism?","volume":"167","author":"Wagenmakers","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP161721.RA_bb0160","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jcem-67-6-1122","article-title":"Muscle and adipose tissue morphology and metabolism in Cushing's syndrome","volume":"67","author":"Rebuffe-Scrive","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0165","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00198-013-2520-5","article-title":"Bone complications in patients with Cushing's syndrome: looking for clinical, biochemical, and genetic determinants","volume":"25","author":"Trementino","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.4158\/EP161721.RA_bb0170","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/jc.2005-1058","article-title":"Long-term quality of life in Cushing's syndrome despite initial improvement after surgical improvement after surgical remission","volume":"91","author":"Lindsay","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0175","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/cen.12098","article-title":"False positives on both dexamethasone testing and urinary free cortisol in women on oral contraception: dose-response effects","volume":"79","author":"Paschali","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161721.RA_bb0180","first-page":"955","article-title":"Oral contraception but not menstrual cycle phase is associated with increased free cortisol levels and low hypothalamo-pituitary-adrenal axis reactivity","volume":"36","author":"Boisseau","year":"2013","journal-title":"J Endocrinol Invest"},{"key":"10.4158\/EP161721.RA_bb0185","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/cen.12259","article-title":"High variability in baseline urinary free cortisol values in patients with Cushing's disease","volume":"80","author":"Petersenn","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161721.RA_bb0190","first-page":"647","article-title":"The diagnosis and differential diagnosis of Cushing's syndrome and Pseudo-Cushing's states","volume":"19","author":"Newell-Price","year":"1998","journal-title":"Endo Rev"},{"key":"10.4158\/EP161721.RA_bb0195","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1210\/jc.2009-1166","article-title":"Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency","volume":"94","author":"Raff","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0200","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1067\/mpd.2000.106226","article-title":"Nighttime salivary cortisol measurement as a simple, noninvasive, outpatient screening test for Cushing's syndrome in children and adolescents","volume":"137","author":"Gafni","year":"2000","journal-title":"J Pediatr"},{"key":"10.4158\/EP161721.RA_bb0205","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2265.1995.tb02918.x","article-title":"A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome","volume":"43","author":"Newell-Price","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161721.RA_bb0210","first-page":"1163","article-title":"A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states","volume":"83","author":"Papanicolaou","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0215","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1210\/jc.2003-030207","article-title":"The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome","volume":"89","author":"Findling","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0220","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1001\/jama.1993.03500170062035","article-title":"Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states","volume":"269","author":"Yanovski","year":"1993","journal-title":"JAMA"},{"key":"10.4158\/EP161721.RA_bb0225","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1210\/jc.2009-1500","article-title":"Concomitant medication use can confound interpretation of the combined dexamethasone-corticotropin releasing hormone test in Cushing's syndrome","volume":"94","author":"Valassi","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0230","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1210\/jc.2007-1289","article-title":"Editorial: The dexamethasone-suppressed corticotropin-releasing hormone test for the diagnosis of Cushing's syndrome: what we have learned in 14 years","volume":"92","author":"Nieman","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0235","doi-asserted-by":"crossref","first-page":"R205","DOI":"10.1530\/EJE-16-0946","article-title":"Diagnosis of Endocrine Disease: Differentiation of pathologic\/neoplastic hypercortisolism (Cushing's syndrome) from physiologic\/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing's syndrome)","volume":"176","author":"Findling","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP161721.RA_bb0240","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/clinchem\/35.4.596","article-title":"A new immunoradiometric assay for corticotropin evaluated in normal subjects and patients with Cushing's syndrome","volume":"35","author":"Raff","year":"1989","journal-title":"Clin Chem"},{"key":"10.4158\/EP161721.RA_bb0245","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1590\/S0004-27302007000800009","article-title":"Primary pigmented nodular adrenocortical disease and Cushing's syndrome","volume":"51","author":"Horvath","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.4158\/EP161721.RA_bb0250","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/0003-4819-131-8-199910190-00006","article-title":"Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease","volume":"131","author":"Stratakis","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP161721.RA_bb0255","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa1304603","article-title":"ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome","volume":"369","author":"Assi\u00e9","year":"2013","journal-title":"N Eng J Med"},{"key":"10.4158\/EP161721.RA_bb0260","doi-asserted-by":"crossref","first-page":"E1113","DOI":"10.1210\/jc.2013-4280","article-title":"Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: A clinical and genetic investigation","volume":"99","author":"Faucz","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0265","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.4158\/EP15662.OR","article-title":"Pituitary MRI findings in patients with pituitary and ectopic ACTH-dependent Cushing's syndrome: Does a 6 mm pituitary tumor size cut-off value exclude ectopic ACTH syndrome?","volume":"21","author":"Yogi-Morren","year":"2015","journal-title":"Endocr Pract"},{"key":"10.4158\/EP161721.RA_bb0270","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1210\/jc.2002-021438","article-title":"Spoiled gradient recalled acquisition in the steady state technique is superior to conventional postcontrast spin echo technique for magnetic resonance imaging detection of adrenocorticotropin-secreting pituitary tumors","volume":"88","author":"Patronas","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0275","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1210\/jc.2012-3943","article-title":"The lateralization accuracy of inferior petrosal sinus sampling in 501 patients with Cushing's disease","volume":"98","author":"Wind","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0280","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-120-10-199405150-00001","article-title":"Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population","volume":"120","author":"Hall","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP161721.RA_bb0285","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1210\/jcem.78.2.8106630","article-title":"A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome","volume":"78","author":"Dicheck","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0290","first-page":"1780","article-title":"Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome","volume":"82","author":"Aron","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0295","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0889-8529(05)70209-7","article-title":"Diagnosis and differential diagnosis of Cushing's syndrome","volume":"30","author":"Findling","year":"2001","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.4158\/EP161721.RA_bb0300","first-page":"1308","article-title":"A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome","volume":"77","author":"Nieman","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0305","first-page":"1640","article-title":"Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome","volume":"87","author":"Newell-Price","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0310","first-page":"412","article-title":"A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis","volume":"80","author":"Trainer","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0315","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/jcem-69-1-165","article-title":"The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for the diagnosis of Cushing's disease","volume":"69","author":"Nieman","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0320","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/B978-0-444-59602-4.00015-0","article-title":"Cushing's disease","volume":"124","author":"Tritos","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.4158\/EP161721.RA_bb0325","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM199109263251301","article-title":"Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome","volume":"325","author":"Oldfield","year":"1991","journal-title":"N Eng J Med"},{"key":"10.4158\/EP161721.RA_bb0330","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1210\/jc.2003-032249","article-title":"Diagnostic errors after inferior petrosal sinus sampling","volume":"89","author":"Swearingen","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0335","first-page":"533","article-title":"The hypoplastic inferior petrosal sinus: a potential source of false-negative results in petrosal sampling for Cushing's disease","volume":"84","author":"Doppman","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0340","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1210\/jc.2004-1378","article-title":"Identification of patients with Cushing's disease with negative pituitary adrenocorticotropin gradients during inferior petrosal sinus sampling: Prolactin as an index of pituitary venous effluent","volume":"89","author":"Findling","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0345","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1210\/jc.2011-2149","article-title":"Prolactin as a marker of successful catheterization during IPSS in patients with ACTH-dependent Cushing's syndrome","volume":"96","author":"Sharma","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0350","first-page":"305","article-title":"Pitfall of petrosal sinus sampling in a Cushing's syndrome secondary to ectopic adrenocorticotropin-corticotropin releasing hormone (ACTH-CRH) secretion","volume":"83","author":"Young","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0355","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1056\/NEJM198501103120207","article-title":"Preoperative localization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling","volume":"312","author":"Oldfield","year":"1985","journal-title":"N Eng J Med"},{"key":"10.4158\/EP161721.RA_bb0360","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1365-2265.2012.04339.x","article-title":"Prolactin measurement during inferior petrosal sinus sampling improves the localization of pituitary adenomas in Cushing's disease","volume":"77","author":"Mulligan","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161721.RA_bb0365","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1210\/jc.2009-2282","article-title":"Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropin-secreting tumors","volume":"95","author":"Zemskova","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0370","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF00169802","article-title":"Somatostatin analogue scintigraphy in carcinoid tumours","volume":"20","author":"Kwekkeboom","year":"1993","journal-title":"Eur J Nucl Med"},{"key":"10.4158\/EP161721.RA_bb0375","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1677\/JME-08-0110","article-title":"Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro","volume":"42","author":"de Bruin","year":"2009","journal-title":"J Mol Endocrinol"},{"key":"10.4158\/EP161721.RA_bb0380","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1210\/jc.2011-1264","article-title":"Mifepristone effects on tumor somatostatin receptor expression in two patients with Cushing's syndrome due to ectopic adrenocorticotropin secretion","volume":"97","author":"de Bruin","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0385","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.2967\/jnumed.109.066639","article-title":"A comparison of 68Ga-DOTATATE and 18F-FDG PET\/CT in pulmonary neuroendocrine tumors","volume":"50","author":"Kayani","year":"2009","journal-title":"J Nucl Med"},{"key":"10.4158\/EP161721.RA_bb0390","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1210\/JC.2015-1589","article-title":"Conventional and Nuclear Medicine Imaging in Ectopic Cushing's Syndrome: A Systematic Review","volume":"100","author":"Isidori","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0395","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1210\/jc.2003-031812","article-title":"The role of [(18)F]fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenet riaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing's syndrome","volume":"89","author":"Pacak","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0400","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1210\/jc.2004-1938","article-title":"Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography","volume":"90","author":"Orlefors","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0405","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1148\/radiology.184.1.1319078","article-title":"Corticotropin-secreting carcinoid tumors of the thymus: diagnostic unreliability of thymic vein sampling","volume":"184","author":"Doppman","year":"1992","journal-title":"Radiology"},{"key":"10.4158\/EP161721.RA_bb0410","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2265.2002.01511.x","article-title":"Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single center using strict criteria for remission","volume":"56","author":"Rees","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161721.RA_bb0415","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1210\/jc.2011-0456","article-title":"The postoperative basal cortisol and CRH tests for prediction of long-term remission from Cushing's disease after transsphenoidal surgery","volume":"96","author":"Lindsay","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0420","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1210\/jc.2013-1470","article-title":"Clinical review: Outcome of bilateral adrenalectomy in Cushing's syndrome: a systematic review","volume":"98","author":"Ritzel","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0425","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1210\/jc.2006-1328","article-title":"Corticotroph tumor progression after adrenalectomy in Cushing's disease. A reappraisal of Nelson's syndrome","volume":"92","author":"Assi\u00e9","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0430","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3171\/2013.7.JNS13389","article-title":"Effect of stereotactic radiosurgery before bilateral adrenalectomy for Cushing's disease on the incidence of Nelson's syndrome","volume":"119","author":"Mehta","year":"2013","journal-title":"J Neurosurg"},{"key":"10.4158\/EP161721.RA_bb0435","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1056\/NEJM199701163360303","article-title":"The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease","volume":"336","author":"Estrada","year":"1997","journal-title":"N Eng J Med"},{"key":"10.4158\/EP161721.RA_bb0440","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1210\/jc.2012-3126","article-title":"Medical treatment of Cushing's disease","volume":"98","author":"Feelders","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0445","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s11102-016-0742-1","article-title":"Updates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapies","volume":"19","author":"Fleseriu","year":"2016","journal-title":"Pituitary"},{"key":"10.4158\/EP161721.RA_bb0450","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0455","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1210\/jc.2013-3628","article-title":"Ketoconazole in Cushing's disease: is it worth a try?","volume":"99","author":"Castinetti","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0460","unstructured":"Food and Drug Administration Drug Safety Announcement: FDA limits usage of Nizoral (ketoconazole) oral tablets due to potentially fatal liver injury and risk of drug interactions and adrenal gland problems. 2013;."},{"key":"10.4158\/EP161721.RA_bb0465","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1210\/jc.2015-2616","article-title":"Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients","volume":"100","author":"Daniel","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161721.RA_bb0470","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1530\/EJE-12-0358","article-title":"Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center","volume":"167","author":"Baudry","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP161721.RA_bb0475","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1530\/EJE-12-0274","article-title":"Etomidate in the management of hypercortisolaemia in Cushing's syndrome: a review","volume":"167","author":"Preda","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP161721.RA_bb0480","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJMoa1105743","article-title":"A 12-month phase 3 study of pasireotide in Cushing's disease","volume":"366","author":"Colao","year":"2012","journal-title":"N Engl J Med"},{"key":"10.4158\/EP161721.RA_bb0485","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1530\/EJE-10-0382","article-title":"Cabergoline monotherapy in the long-term treatment of Cushing's disease","volume":"163","author":"Godbout","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP161721.RA_bb0490","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1210\/jc.2011-3350","article-title":"Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome","volume":"97","author":"Fleseriu","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20358110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20358110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:02:54Z","timestamp":1761516174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20358110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":97,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1530891X20358110"],"URL":"https:\/\/doi.org\/10.4158\/ep161721.ra","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Individualized Approach to the Evaluation of Cushing Syndrome","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP161721.RA","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}